The measurement of FeNO is a quantitative, non-invasive, simple, and safe method for measuring airway inflammation, and is a complementary tool for assessing other respiratory diseases, including asthma (
16). In a comparison of arginine isoforms and various types of CRS in 2015, it was reported that exhaled NO is an appropriate marker for the differentiation of CRP phenotypes based on the balance between the activity of arginase and NOS in the production of NO (
17).
In a study of 110 patients with asthma in 2014, it was concluded that in patients with mild-to-moderate and severe asthma, blood eosinophils had the highest accuracy in detecting eosinophilic sputum in asthma. The use of blood eosinophils can facilitate individual treatment and management of asthma (
18). In a study conducted by Weschta et al. in 2008, they evaluated the performance of a new handheld nitric oxide (NO) analyzer for measuring nasal fractional exhaled respiratory nitric oxide. They concluded that the NIOX MINO Airway monitor (Inflammation Monitor NO) is suitable for measuring nasal FeNO. This may be useful in differentiating hyperplasic eosinophil rhinosinusitis from non-specific CRS. Additionally, nasal FeNO can be used in monitoring the clinical course of CRS with polyps (
19). In another study, in 2012, 36 patients with nasal polyposis with eosinophil (ECRS) were treated with either medical or surgical nasal polyps; the evaluation of oral and nasal FeNO levels was done by using an electrochemical NO analyzer in the first and the sixth months. Micro-RNA expression of nitric oxide synthesis (NOS) isoforms in the nasal mucosa and nasal polyposis was analyzed by Polymerase Chain Reaction (PCR) and immunohistochemistry. They concluded that the combination of oral and nasal measurement of FeNO was useful in controlling inflammation in CRS patients. Increasing nasal FeNO levels in the surgical group indicated a rapid improvement in the release of NO from sinus ostia sinus mucus, and the reduction of the oral FeNO level may reflect more severe inflammation of the lower respiratory tract at ECRS (
20).
In 1999, Kawamoto et al. conducted a study on two normal and allergic groups exposed to home-made dust. In this study, the expression of iNOS significantly increased in epithelial cells of the allergic group compared to the control group, and this increase in expression happened due to the secretion of pro-inflammatory cytokines (
21). In 2005, a study on 100 Thai children with a clinical diagnosis of RS and sinusitis showed that 53% of the patients had a positive prick test for allergens, which confirmed the relationship between the two diseases (
22). In 2007, Naraghi et al. reported that the level of NO metabolites in the maxillary sinuses of individuals with chronic sinusitis significantly increased and led to the destruction of the epithelium of the sinuses and could contribute to the pathogenesis of sinusitis (
23). In 2010, Guida et al. studied 93 patients diagnosed with CRS, and suggested that the presence of polyps in patients diagnosed with CRS was associated with an increased prevalence of asthma and the exhaled NO level. They also reported that respiratory symptoms without severe bronchospasm, with eosinophilic inflammation of the air tracks, and an increased exhaled NO were related only to patients with nasal polyposis. This is a very important point in distinguishing between the two groups of CRS with or without nasal polyps (
24). In 2012, Lee et al. found that the concentration of nasal NO was much higher in patients diagnosed with allergic rhinitis than in normal people, by examining the level of nasal and exhaled NO. Also, in the absence of asthma, allergic rhinitis patients had a higher level of exhaled NO than the normal control group. On the other hand, those with resistant allergic rhinitis had higher exhaled NO concentrations, while there was a lower concentration of nasal NO compared to the control group so that in the severe stages of the disease and rhinitis, which are resistant to NO treatment, nasal NO can be reduced (
25). In 2014, Green et al. studied the sensitivity of CRS patients and reported that a high percentage of patients with positive CRS had Positive Prick Test (SPT), and the highest sensitivity in these patients belonged to
A. alternata, cat, and Ragweed (
15). On the other hand, the role of fungi in CRS has led to a great deal of controversy over CRS. The use of sensitive detection techniques has shown that fungi exist in the intranasal state of all populations, whether patients or healthy, and it can be said that fungi exist in the intranasal of 100% of the population, both CRS and control. This finding suggests that fungi do not significantly correlate with FeNO. However, CRS patients have eosinophils in the nasal and lumen tissues compared to controls and this shows an allergic reaction without increasing IgE levels. These observations suggest a hypothesis: It has been reported that those over-hosting reactions that do not occur through IgE occur as a result of common aerobic fungi that are major causes of the disease in these reactions in most forms of CRS, polyps, and non-polyps. Our findings in this study are parallel to a previous finding (
26). In 2013, a comparison of nasal NO level in patients with CRS diagnosis and patients with a diagnosis of colds was done. In this study, the NO concentration was not associated with the symptom score, endoscopic findings, and CT scan, although the nasal NO concentration was not significantly different in cold patients and normal groups. The level of nasal NO was significantly lower in patients diagnosed with CRS than in two other groups (
11). In 2015, a study on the comparison of arginine isoforms and various types of CRS subtypes showed that exhaled NO, which was based on the balance between the activity of arginase and NOS in the production of NO, can be an appropriate marker to diagnose various phenotypes of CRS (
17).
5.1. Conclusion
This study showed that most people with CRSwNP have a sensitivity to at least one indoor aeroallergen, and cockroaches are the most common allergen in patients with CRSwNP with a prevalence of 17.9%.
The percentage of eosinophils in the nasal mucosa was significantly related to FeNO, and it can be concluded that this index can well predict the FeNO level in these patients. However, the correlation between FeNO and the severity of sinus involvement in CT findings was not significant, and it can be said that CT findings are not an appropriate indicator for the measurement of FeNO, and thus, it is not useful for treatment follow-up and response to treatment in patients.
This study showed that the correlation of FeNO with the sensitivity of these patients to home aeroallergens can be used and this correlation for mosquito and cockroach aeroallergens is very valuable, but for fungi, this correlation had the lowest value of 0.748. Another result of this study is that if nitric oxide levels were considered at three levels of normal (< 20 - 25 ppb), elevated (25 - 50 ppb), and high (> 50 ppb), compared to prick testing of aeroallergens, they could be used to estimate the relapse or lack of appropriate response to medical treatment in patients with CRSwNP. In addition, this study showed that the highest correlation was found between nitric oxide and mosquito and cockroach aeroallergens.
The only limitation of this study was the number of patients.